Skip to Main Content

Author Details

Rebecca Kusko
Immuneering Corporation
2012
33
18
PMIDPaper TitleJournal TitlePublished Year
34980216Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.Genome Biol2022
35680918Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies.Sci Data2022
35768876Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples.Genome Biol2022
36514120Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies.Genome Biol2022
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
35475002Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA.Cell Rep Methods2021
33901609A primer on applying AI synergistically with domain expertise to oncology.Biochim Biophys Acta Rev Cancer2021
33846644Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.Nat Biotechnol2021
33863366A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Genome Biol2021
33863344Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Genome Biol2021
35282311FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology.Precis Cancer Med2021
34789871Reporting guidelines for human microbiome research: the STORMS checklist.Nat Med2021
34504347Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.Nat Biotechnol2021
32586380Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19).J Transl Med2020
32978366pS421 huntingtin modulates mitochondrial phenotypes and confers neuroprotection in an HD hiPSC model.Cell Death Dis2020
32692251Quantitative Structure-Activity Relationship Models for Predicting Inflammatory Potential of Metal Oxide Nanoparticles.Environ Health Perspect2020
31092200Correction to: Similarities and differences between variants called with human reference genome HG19 or HG38.BMC Bioinformatics2019
29551586Integrity, standards, and QC-related issues with big data in pre-clinical drug discovery.Biochem Pharmacol2018
29867496Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations.Front Pharmacol2018
30633647Computational prediction models for assessing endocrine disrupting potential of chemicals.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev2018
28369768Drug repurposing from the perspective of pharmaceutical companies.Br J Pharmacol2018
29783994Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.Mol Neurodegener2018
27780809Letter to the Editor response: Nygaard et al.Biostatistics2017
29220036The international MAQC Society launches to enhance reproducibility of high-throughput technologies.Nat Biotechnol2017
29212949Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.JCI Insight2017
28569182A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis.Genome Med2017
27818324The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.Neurobiol Dis2017
27104832Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med2016
27960087Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.Cancer Cell2016
27466197Pridopidine activates neuroprotective pathways impaired in Huntington Disease.Hum Mol Genet2016
24469837PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.Mol Cancer Res2014
24195059Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis.Front Oncol2013
22676806Premature expression of a muscle fibrosis axis in chronic HIV infection.Skelet Muscle2012
  • 1 - 33 of 33

Recommended Authors

Hailiang Mei
Leiden University Medical Center
Career Start Year 2014
Number of shared co-authors 1
Asha A Nair
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 3
Subha Madhavan
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Career Start Year 2009
Number of shared co-authors 2
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Career Start Year 2009
Number of shared co-authors 0
Stephen R Piccolo
Brigham Young University
Career Start Year 2008
Number of shared co-authors 2
Joel T Dudley
Institute for Next Generation Healthcare
Career Start Year 2006
Number of shared co-authors 6
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 2
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 4
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 2
Agnes C Paquet
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
Sophia Jeng
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 1
Zhandong Liu
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital
Career Start Year 2003
Number of shared co-authors 1
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 7
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 3
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 3
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 17
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 1
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Cory C Funk
Institute for Systems Biology
Career Start Year 1999
Number of shared co-authors 0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 3
Wim Van Criekinge
Ghent University
Career Start Year 1995
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 2
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 16

Collaborators

Weida Tong
National Center for Toxicological Research
Co-authored papers 14
Wendell D Jones
Department of Bioinformatics and Clinical Systems
Co-authored papers 9
Huixiao Hong
Co-authored papers 8
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers 8
Andreas Scherer
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 7
Joshua Xu
Co-authored papers 7
Ming Shi
Co-authored papers 7
Michael R Hayden
Co-authored papers 6
Donald J Johann
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Co-authored papers 6
James C Willey
Co-authored papers 6
Baitang Ning
Co-authored papers 6
Chunlin Xiao
Chongqing Aier Eye Hospital
Co-authored papers 6
Wenzhong Xiao
Stanford University
Co-authored papers 5
Zhichao Liu
Co-authored papers 5
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers 5
Tieliu Shi
Co-authored papers 4
Cesare Furlanello
Bruno Kessler Foundation
Co-authored papers 4
Jonathan Foox
Co-authored papers 4
Quan-Zhen Li
Co-authored papers 4
Tim R Mercer
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 4
Wenjun Bao
SAS Institute Inc Cary
Co-authored papers 4
Xiaohui Fan
College of Life Sciences, Zhejiang University
Co-authored papers 3
Erich Jaeger
Illumina Inc.
Co-authored papers 3
Sayed Mohammad Ebrahim Sahraeian
Roche Sequencing Solutions Inc.
Co-authored papers 3
Pierre R Bushel
Co-authored papers 3
Gary P Schroth
Co-authored papers 3
Hong Fang
National Center for Toxicological Research (NCTR)
Co-authored papers 3
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Charles Wang
Co-authored papers 3
Zhiguang Li
Co-authored papers 3
Release 1.2